Search

everythinglearnresearchcommunity

for

Search:↓

Eating the right nutrients can improve hair health, but taking extra supplements usually doesn't help unless you have a deficiency.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

No cure for female pattern hair loss, but various effective treatments exist.

Doctors need to be better prepared to assess and treat obesity in patients.

Fat from the body can help improve hair growth and scars when used in skin treatments.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal therapies are safe and effective for treating adult women's acne.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Stem cell therapy may help treat tough hair loss cases.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Ginsenoside Rb1 from Panax ginseng helps mink hair grow by activating certain cell signals.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Both genetic and lifestyle factors significantly affect female hair loss.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Some chemicals absorbed through the skin can cause serious health problems.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Micro-current stimulation may promote hair growth more effectively than standard treatments.

3D cell-derived matrices improve tissue regeneration and disease modeling.